Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats

Shingo, 2012, Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus, Behavioural Brain Research, 229, 378, 10.1016/j.bbr.2012.01.034 Banks, 2004, The source of cerebral insulin, European Journal of Pharmacology, 490, 5, 10.1016/j.ejphar.2004.02.040 Plata-Salamán, 1991, Insulin in the cerebrospinal fluid, Neuroscience and Biobehavioral Reviews, 15, 243, 10.1016/S0149-7634(05)80004-1 Schechter, 2001, Neuronal synthesized insulin roles on neural differentiation within fetal rat neuron cell cultures, Brain Research. Developmental Brain Research, 127, 41, 10.1016/S0165-3806(01)00110-9 Schechter, 1996, Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system, Brain Research, 736, 16, 10.1016/0006-8993(96)00664-6 Schechter, 1992, Developmental regulation of insulin in the mammalian central nervous system, Brain Research, 582, 27, 10.1016/0006-8993(92)90313-X Devaskar, 1994, Insulin gene expression and insulin synthesis in mammalian neuronal cells, The Journal of Biological Chemistry, 269, 8445, 10.1016/S0021-9258(17)37214-9 Santos, 1999, Stimulation of immunoreactive insulin release by glucose in rat brain synaptosomes, Neurochemical Research, 24, 33, 10.1023/A:1020971812098 Gerozissis, 2003, Brain insulin: regulation, mechanisms of action and functions, Cellular and Molecular Neurobiology, 23, 1, 10.1023/A:1022598900246 Gerozissis, 2009, Function (and dysfunctions) of insulin in the brain, Journal of the Japan Diabetes Society, 52, 333 Hellweg, 1992, Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism, Journal of Neuroscience Research, 31, 479, 10.1002/jnr.490310310 Nitsch, 1991, Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex, Neuroscience Letters, 128, 199, 10.1016/0304-3940(91)90260-Z Mayer, 1990, Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats, Brain Research, 532, 95, 10.1016/0006-8993(90)91747-5 Hoyer, 1991, Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases, Journal of Neural Transmission. Parkinson's Disease and Dementia Section, 3, 1, 10.1007/BF02251132 Grünblatt, 2007, Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein, Journal of Neurochemistry, 101, 757, 10.1111/j.1471-4159.2006.04368.x Agrawal, 2011, Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model, European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 21, 261, 10.1016/j.euroneuro.2010.11.009 Hawkins, 2007, Decreased blood–brain barrier permeability to fluorescein in streptozotocin-treated rats, Neuroscience Letters, 411, 1, 10.1016/j.neulet.2006.09.010 Serlin, 2011, Vascular pathology and blood–brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus, Cardiovascular Psychiatry and Neurology, 2011, 609202, 10.1155/2011/609202 Vannucci, 1997, Glucose utilization and glucose transporter proteins GLUT-1 and GLUT-3 in brains of diabetic (db/db) mice, The American Journal of Physiology, 272, E267 Pardridge, 1990, Downregulation of blood–brain barrier glucose transporter in experimental diabetes, Diabetes, 39, 1040, 10.2337/diab.39.9.1040 Craft, 1998, Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype, Neurology, 50, 164, 10.1212/WNL.50.1.164 Qiu, 2006, Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis, Neurobiology of Aging, 27, 190, 10.1016/j.neurobiolaging.2005.01.004 Pérez, 2000, Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains, Neurochemical Research, 25, 247, 10.1023/A:1007527721160 Iwata, 2002, Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging, Journal of Neuroscience Research, 70, 493, 10.1002/jnr.10390 Saito, 2005, Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation, Nature Medicine, 11, 434, 10.1038/nm1206 Ciaccio, 2009, Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity, Journal of Molecular Biology, 385, 1556, 10.1016/j.jmb.2008.11.025